Literature DB >> 10951299

Treatment of nasolacrimal duct obstruction in children with trisomy 21.

G T Lueder1.   

Abstract

BACKGROUND: Nasolacrimal duct (NLD) obstruction and tear film abnormalities occur frequently in children with trisomy 21. This study describes the outcomes of treatment for NLD obstruction in this population.
METHODS: The records of 15 children with trisomy 21 treated for NLD obstruction were reviewed. Eight patients were initially treated with NLD probing with or without placement of nonfixated lacrimal stents. Because of poor success with this procedure, the initial treatment of children with trisomy 21 and NLD obstruction was changed to balloon catheter dilation in 1997. Outcomes were considered excellent if the patient had complete resolution of epiphora and dacryocystitis, good if the patient had only mild residual symptoms, fair if the patient had significant residual symptoms, and poor if there was no improvement.
RESULTS: Of 8 patients treated initially with NLD probing, 5 had fair or poor outcomes. These patients all had good outcomes after placement of nasally fixated lacrimal stents, balloon catheter dilation, or both. Of 7 patients treated initially with balloon catheter dilation, 5 had excellent or good outcomes and 2 had fair or poor outcomes.
CONCLUSION: Simple NLD probing is often unsuccessful in treating NLD obstruction in children with trisomy 21. Balloon catheter dilation appears to be a reasonable alternative first treatment in these patients.

Entities:  

Mesh:

Year:  2000        PMID: 10951299     DOI: 10.1067/mpa.2000.105272

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  2 in total

1.  High-resolution dacryoendoscopy for observation for pediatric lacrimal duct obstruction.

Authors:  Nozomi Matsumura; Satoshi Goto; Shin Yamane; Takeshi Fujita; Maiko Inoue; Mikio Inamura; Kazuaki Kadonosono
Journal:  Am J Ophthalmol Case Rep       Date:  2016-03-21

Review 2.  Down syndrome: a review of ocular manifestations.

Authors:  Abid Haseeb; Elisah Huynh; Reem H ElSheikh; Ahmed S ElHawary; Christina Scelfo; Danielle M Ledoux; Daniel E Maidana; Abdelrahman M Elhusseiny
Journal:  Ther Adv Ophthalmol       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.